CROLOM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Crolom, and what generic alternatives are available?
Crolom is a drug marketed by Bausch And Lomb and is included in one NDA.
The generic ingredient in CROLOM is cromolyn sodium. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Crolom
A generic version of CROLOM was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CROLOM?
- What are the global sales for CROLOM?
- What is Average Wholesale Price for CROLOM?
Summary for CROLOM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 98 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,783 |
| DailyMed Link: | CROLOM at DailyMed |
Recent Clinical Trials for CROLOM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Diego | Phase 1/Phase 2 |
US Patents and Regulatory Information for CROLOM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | CROLOM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 074443-001 | Jan 30, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
